![aRCC: 1L Treatment Options and Patient Management](http://media.vumedi.com/thumbs/channel_logo/2022/9/60735544-fe62-43a8-921f-e700719e64d6.png.200x0_q85.png)
aRCC: 1L Treatment Options and Patient Management
GU Tumor Board: 61 y/o Male With mRCC With Disease Progression After Multiple Lines of Systemic Therapy
205 views
December 28, 2022
Comments 1
Login to view comments.
Click here to Login